Emicizumab

Tax included
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis. Emicizumab can be used for hemophilia A research.
MedChemExpress 
HY-P9940

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
Neuroscience-Neuromodulation
CAS
1610943-06-0